Steven J. O’Day, MD
The John Wayne Cancer Institute
Dr. O’Day, is the Executive Director of John Wayne Cancer Institute and Cancer Clinic at Providence Saint John’s Health Center, Director of Providence Los Angeles Regional Research, and a Professor of Medical Oncology. A board-certified medical oncologist, Dr. O’Day is recognized as one of the world’s preeminent melanoma specialists. Dr. O’Day has been at the forefront of new drug development and immunotherapies for melanoma and other cancers for the last two decades. He has been a principal investigator for more than 100 clinical trials, including several large, international phase 3 studies. He lectures extensively, both nationally and internationally, and has published more than 200 scientific articles, abstracts and reviews in prestigious peer-reviewed journals. Dr. O’Day received his medical training at Johns Hopkins in Baltimore and the Dana Farber Cancer Institute in Boston.
Caroline Robert, MD, PhD
Dr. Robert is a scientist of international renown for establishing the role of immune therapies in advanced melanoma through groundbreaking work on the clinical trials evaluating anti–CTLA-4 as well as anti-PD1 antibodies. She is head of the Dermatology Unit at the Institut Gustave-Roussy, Paris, France and previously was medical director for Johnson & Johnson Consumer Europe. Dr. Robert received her medical degree at the Cochin Port-Royal School of Medicine, Paris, followed by French Board Certification in dermatology. She completed a research fellowship at Harvard University and a PhD in cancer immunology and immunotherapy. She has authored more than 250 articles in peer-reviewed scientific journals, including publications on new treatments for metastatic melanoma, and has been at the forefront in numerous international clinical trials.
Triple Negative Breast Cancer
Joyce A. O’Shaughnessy, MD
Texas Oncology | Baylor Sammons Cancer Center | US Oncology Network
Dr. O’Shaughnessy is a nationally recognized breast cancer researcher and clinician. At Baylor University Medical Center, she is Chair of Breast Cancer Research and the Celebrating Women Chair in Breast Cancer at Baylor’s Charles A. Sammons Cancer Center. Dr. O’Shaughnessy is also Chair of the U.S. Oncology Clinical Breast Cancer Trials committee. She received her M.D. from Yale University Medical School. Dr. O’Shaughnessy completed a medical oncology fellowship at the National Cancer Institute and eventually became a senior investigator at NCI before joining Texas Oncology.